Vito Di Lernia

3.7k total citations
113 papers, 1.7k citations indexed

About

Vito Di Lernia is a scholar working on Dermatology, Immunology and Rheumatology. According to data from OpenAlex, Vito Di Lernia has authored 113 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Dermatology, 43 papers in Immunology and 25 papers in Rheumatology. Recurrent topics in Vito Di Lernia's work include Psoriasis: Treatment and Pathogenesis (37 papers), Dermatology and Skin Diseases (23 papers) and Autoimmune Bullous Skin Diseases (17 papers). Vito Di Lernia is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (37 papers), Dermatology and Skin Diseases (23 papers) and Autoimmune Bullous Skin Diseases (17 papers). Vito Di Lernia collaborates with scholars based in Italy, United States and Austria. Vito Di Lernia's co-authors include Cinzia Ricci, Giuseppe Argenziano, Aimilios Lallas, Iris Zalaudek, Iria Neri, Caterina Longo, Mohamad Goldust, Zoé Apalla, Giuseppe Albertini and Annalisa Patrizi and has published in prestigious journals such as Journal of the American Academy of Dermatology, British Journal of Dermatology and Frontiers in Pharmacology.

In The Last Decade

Vito Di Lernia

108 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vito Di Lernia Italy 24 915 572 363 295 269 113 1.7k
Yong‐Kwang Tay Singapore 25 797 0.9× 196 0.3× 292 0.8× 325 1.1× 378 1.4× 87 1.8k
J. Garioch United Kingdom 21 499 0.5× 482 0.8× 359 1.0× 162 0.5× 265 1.0× 70 1.6k
Vicente García‐Patos Spain 23 602 0.7× 403 0.7× 741 2.0× 419 1.4× 332 1.2× 124 2.0k
Hong‐Shang Hong Taiwan 19 693 0.8× 227 0.4× 327 0.9× 513 1.7× 605 2.2× 67 2.4k
Mar Llamas‐Velasco Spain 21 589 0.6× 531 0.9× 276 0.8× 267 0.9× 242 0.9× 167 1.6k
David R. Berk United States 23 562 0.6× 210 0.4× 277 0.8× 137 0.5× 219 0.8× 109 1.6k
Sylvia Hsu United States 23 1.0k 1.1× 1.1k 2.0× 326 0.9× 460 1.6× 613 2.3× 142 2.2k
Kelly M. Cordoro United States 23 793 0.9× 637 1.1× 184 0.5× 123 0.4× 148 0.6× 69 1.6k
Sylvia Hsu United States 18 474 0.5× 228 0.4× 350 1.0× 223 0.8× 207 0.8× 78 1.2k
Warren R. Heymann United States 18 546 0.6× 111 0.2× 367 1.0× 285 1.0× 307 1.1× 155 1.5k

Countries citing papers authored by Vito Di Lernia

Since Specialization
Citations

This map shows the geographic impact of Vito Di Lernia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vito Di Lernia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vito Di Lernia more than expected).

Fields of papers citing papers by Vito Di Lernia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vito Di Lernia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vito Di Lernia. The network helps show where Vito Di Lernia may publish in the future.

Co-authorship network of co-authors of Vito Di Lernia

This figure shows the co-authorship network connecting the top 25 collaborators of Vito Di Lernia. A scholar is included among the top collaborators of Vito Di Lernia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vito Di Lernia. Vito Di Lernia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bardazzi, Federico, Claudia Lasagni, Laura Bigi, et al.. (2024). Psoriasis With Leg Involvement, a New Difficult-to-Treat Area: A Cohort Study of Patients Treated With Risankizumab. Dermatology Practical & Conceptual. 14(3). e2024171–e2024171. 1 indexed citations
2.
Bardazzi, Federico, Bianca Maria Piraccini, Claudia Lasagni, et al.. (2023). Tildrakizumab in Complex Psoriatic Patients: An Experience in Emilia-Romagna (Italy). Journal of Cutaneous Medicine and Surgery. 27(2). 126–132. 7 indexed citations
3.
Laheru, Dhruvkumar, Sueli Carneiro, Vito Di Lernia, et al.. (2022). Management of Nail Disease in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations. The Journal of Rheumatology. 50(3). jrheum.220313–jrheum.220313. 8 indexed citations
4.
Bardazzi, Federico, Vito Di Lernia, Andrea Conti, et al.. (2022). Guselkumab for the treatment of psoriasis: a 60-week real-life multicenter retrospective experience. Expert Opinion on Biological Therapy. 22(12). 1561–1566. 11 indexed citations
5.
Arora, Pooja, George Kroumpouzos, Ayşe Serap Karadağ, et al.. (2021). New Coronavirus (SARS-CoV-2) Crossing Borders Beyond Cities, Nations, and Continents: Impact of International Travel. Balkan Medical Journal. 38(4). 205–211. 5 indexed citations
6.
Lernia, Vito Di, et al.. (2020). Apremilast in patients with history of malignancy: a real‐life, single‐center experience. International Journal of Dermatology. 60(1). e22–e24. 4 indexed citations
7.
Lernia, Vito Di, et al.. (2020). Pemphigus Vulgaris and Bullous Pemphigoid: Update on Diagnosis and Treatment. Dermatology Practical & Conceptual. 10(3). e2020050–e2020050. 47 indexed citations
8.
Ingordo, Vito, Simone Cazzaniga, Matelda Medri, et al.. (2014). To What Extent Is Quality of Life Impaired in Vitiligo? A Multicenter Study on Italian Patients Using the Dermatology Life Quality Index. Dermatology. 229(3). 240–247. 21 indexed citations
9.
Lernia, Vito Di, Cinzia Ricci, Iris Zalaudek, & Giuseppe Argenziano. (2013). Metastasizing basal cell carcinoma.. PubMed. 92(5). 244–6. 11 indexed citations
10.
Lernia, Vito Di & Yasaman Mansouri. (2013). Epstein–Barr virus and skin manifestations in childhood. International Journal of Dermatology. 52(10). 1177–1184. 43 indexed citations
11.
Lernia, Vito Di, et al.. (2013). Clinical predictors of non-response to any tumor necrosis factor (TNF) blockers: a retrospective study. Journal of Dermatological Treatment. 25(1). 73–74. 46 indexed citations
12.
Lernia, Vito Di, et al.. (2012). Current therapeutic approaches of psoriasis are affected by age at disease onset. Journal of Dermatological Treatment. 25(1). 15–17. 13 indexed citations
13.
Lernia, Vito Di, et al.. (2009). Syringocystadenoma papilliferum developed on sebaceous nevus. Three pediatric cases. 19(2). 83–86. 3 indexed citations
14.
Lernia, Vito Di, et al.. (2001). Carbamazepine-Induced, CD30+, Primary, Cutaneous, Anaplastic Large-Cell Lymphoma. Archives of Dermatology. 137(5). 675–675. 7 indexed citations
15.
Lernia, Vito Di & Rudolf Happle. (2000). Hypertrichosis cubiti: disappearance of an hereditary trait with age. European Journal of Dermatology. 7(4). 257–258. 1 indexed citations
16.
Lernia, Vito Di, et al.. (1998). Pustolosi erosiva del cuoio capelluto. Redia-Giornale Di Zoologia. 133(5). 353–356.
17.
Lernia, Vito Di, et al.. (1994). Epidermolysis Bullosa Simplex Associated With Muscular Dystrophy: A New Case. Pediatric Dermatology. 11(4). 342–345. 7 indexed citations
18.
Patrizi, Annalisa, Vito Di Lernia, Iria Neri, & Filíppo Gherlinzoni. (1992). Eosinophilic pustular folliculitis (Ofuji's disease) and non-Hodgkin lymphoma.. Acta Dermato Venereologica. 72(2). 146–147. 25 indexed citations
19.
Lernia, Vito Di, et al.. (1992). Immunologic contact urticaria syndrome from raw rice. Contact Dermatitis. 27(3). 196–196. 15 indexed citations
20.
Patrizi, Annalisa, et al.. (1991). LICHEN NITIDUS GENERALISE, TRISOMIE 21 ET MEGACOLON CONGENITAL [1]. Annales de Dermatologie et de Vénéréologie. 118(10). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yong‐Kwang Tay Breakdown of academic impact, for papers by J. Garioch Breakdown of academic impact, for papers by Vicente García‐Patos Breakdown of academic impact, for papers by Hong‐Shang Hong Breakdown of academic impact, for papers by Mar Llamas‐Velasco Breakdown of academic impact, for papers by David R. Berk Breakdown of academic impact, for papers by Sylvia Hsu Breakdown of academic impact, for papers by Kelly M. Cordoro Breakdown of academic impact, for papers by Sylvia Hsu Breakdown of academic impact, for papers by Warren R. Heymann
Rankless by CCL
2026